MAPT and Alzheimer disease: Interestingly, both AD and control brain extracts (PBS-3,000g) had comparable total amounts of HMW tau species on SEC analysis (Fig. 6j,k), despite the clear difference in cellular uptake of tau from the AD and control extracts (Fig. 6a–c).